Unlike CAR-T cells, NK cells don’t need genetic modification to recognize a specific threat — they act broadly without customization. However, some NK companies, such as Fate Therapeutics and Cytovia ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Creating cancer therapies based around natural killer cells could offer similar levels of efficacy to CAR-T therapies, but at around one hundredth of the cost. Researchers at MD Anderson Cancer ...

A team of researchers from the Sant Pau Research Institute (IR Sant Pau) has published a study in the Journal of ...

Abstract Title: Biomarker analysis from Phase 2 study of AgenT-797 (invariant natural killer T-cells), botensilimab (a Fc-enhanced CTLA-4 Inhibitor) with balstilimab (anti-PD-1) in PD-1 refractory ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response ...

The main difference between these CAR-NK cells and the FDA-approved CAR-T cell products lies in the ease of manufacturing. Currently, 10-20% of patients who need CAR-T cell therapy can't access ...

2024年8月，国际知名学术期刊《Cureus》上发表的一项临床病例报告，详细记录了一位61岁晚期肝细胞癌患者在接受联合NK细胞治疗方案（DC疫苗+NK细胞+纳武利尤单抗）后，病情得到显著改善。其中，肝脏储备功能显著改善，肝部肿瘤体积大幅减小，为后续 ...

Brain metastases are one of the most severe complications of melanoma, the most aggressive type of skin cancer. Researchers ...